Association between clinical frailty and multidrug-resistant positive cultures in hospitalized older adults

Carmine Siniscalchi1, Nicoletta Cerundolo1, Antonella Tufano2

  • 1Department of Continuity of Care and Multicomplexity, Parma University Hospital, 43126, Parma, Italy.

Insights

Clinical frailty in older adults is linked to multidrug-resistant (MDR) positive cultures. This association may help stratify infection risk and guide infection control in hospitals.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Frailty is a significant predictor of adverse health outcomes in elderly individuals.
  • The relationship between clinical frailty and multidrug-resistant (MDR) organisms in hospitalized older adults requires further investigation.
  • Understanding this link can enhance early risk assessment and infection control strategies.

Purpose of the Study:

  • To investigate the association between clinical frailty and the presence of multidrug-resistant (MDR) positive cultures in hospitalized older adults.
  • To determine if frailty is an independent risk factor for MDR infections in this population.

Main Methods:

  • A prospective, observational, single-center cohort study was conducted.
  • 208 hospitalized patients aged 65 years and older with suspected bacterial infections were included.
  • Frailty was assessed using the Clinical Frailty Scale (CFS) and Primary Care Frailty Index (PC-FI).

Main Results:

  • Frailty increased progressively across culture result groups (negative, non-MDR, MDR+).
  • The prevalence of frailty was higher in patients with MDR+ cultures (83%) compared to non-MDR (70%) and culture-negative groups (56%).
  • Clinical Frailty Scale (CFS) remained associated with MDR-positive culture status in multivariable analysis (OR 1.57, 95% CI 1.17-2.11).

Conclusions:

  • Clinical frailty is associated with MDR-positive cultures in hospitalized older adults.
  • These findings suggest frailty may be a useful marker for MDR infection risk stratification.
  • Further research is needed to confirm these hypothesis-generating findings.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...